ArticleDiagnostics (Basel, Switzerland)2022

Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study.

Kreon Koukoulas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.